{name}
{subtitle}
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)
city
~11 mi. (Großhansdorf, Germany, +158 more cities)
facility
LungenClinic Grosshansdorf GmbH ( Site 0901)
drug
olaparib, +4 more drugs
drug type
chemotherapy, +3 more types
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-small Cell Lung Cancer
city
~11 mi. (Großhansdorf, Germany, +151 more cities)
facility
GSK Investigational Site
drug
niraparib, +1 more drug
drug type
immunotherapy, +1 more type
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
city
~39 mi. (Lübeck, Germany, +226 more cities)
facility
Universitaetsklinikum Schleswig Holstein. ( Site 0346)
drug
enzalutamide, +1 more drug
drug type
hormone therapy, +1 more type
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)
city
~39 mi. (Lübeck, Germany, +140 more cities)
facility
Universitaetsklinikum Schleswig-Holstein-Campus Lubeck ( Site 0215)
drug
lenvatinib, +2 more drugs
drug type
chemotherapy, +2 more types
Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)
city
~39 mi. (Lübeck, Germany, +159 more cities)
facility
Universitaetsklinikum Schleswig-Holstein-Campus Lubeck ( Site 0512)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +1 more type